Cargando…

Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report

We present a case where we evaluated the effectiveness of nebulized fentanyl in the treatment of refractive dyspnea in a patient with chronic obstructive pulmonary disease (COPD) with major complications and comorbidities. Nebulized fentanyl was used to successfully decrease the subjective symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales: Hildreth, Leah, Pett, Danielle, Higgins, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596332/
https://www.ncbi.nlm.nih.gov/pubmed/33145156
http://dx.doi.org/10.1016/j.rmcr.2020.101251
_version_ 1783602090119004160
author Hildreth, Leah
Pett, Danielle
Higgins, Elizabeth
author_facet Hildreth, Leah
Pett, Danielle
Higgins, Elizabeth
author_sort Hildreth, Leah
collection PubMed
description We present a case where we evaluated the effectiveness of nebulized fentanyl in the treatment of refractive dyspnea in a patient with chronic obstructive pulmonary disease (COPD) with major complications and comorbidities. Nebulized fentanyl was used to successfully decrease the subjective symptoms of refractory dyspnea in this given patient. Nebulized fentanyl appears to be a cost-effective treatment option in patients that experience episodes of severe shortness of breath (SOB).
format Online
Article
Text
id pubmed-7596332
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75963322020-11-02 Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report Hildreth, Leah Pett, Danielle Higgins, Elizabeth Respir Med Case Rep Case Report We present a case where we evaluated the effectiveness of nebulized fentanyl in the treatment of refractive dyspnea in a patient with chronic obstructive pulmonary disease (COPD) with major complications and comorbidities. Nebulized fentanyl was used to successfully decrease the subjective symptoms of refractory dyspnea in this given patient. Nebulized fentanyl appears to be a cost-effective treatment option in patients that experience episodes of severe shortness of breath (SOB). Elsevier 2020-10-12 /pmc/articles/PMC7596332/ /pubmed/33145156 http://dx.doi.org/10.1016/j.rmcr.2020.101251 Text en © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Hildreth, Leah
Pett, Danielle
Higgins, Elizabeth
Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report
title Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report
title_full Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report
title_fullStr Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report
title_full_unstemmed Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report
title_short Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report
title_sort nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (copd): a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596332/
https://www.ncbi.nlm.nih.gov/pubmed/33145156
http://dx.doi.org/10.1016/j.rmcr.2020.101251
work_keys_str_mv AT hildrethleah nebulizedfentanylforrefractorydyspneasecondarytochronicobstructivepulmonarydiseasecopdacasereport
AT pettdanielle nebulizedfentanylforrefractorydyspneasecondarytochronicobstructivepulmonarydiseasecopdacasereport
AT higginselizabeth nebulizedfentanylforrefractorydyspneasecondarytochronicobstructivepulmonarydiseasecopdacasereport